CTMX vs MSFT: Which Stock is Better?
Side-by-side comparison of Cytomx Therapeutics Inc and Microsoft Corp in 2026
CTMX
Cytomx Therapeutics Inc
$4.82
MSFT
Microsoft Corp
$417.51
Key Metrics Comparison
| Metric | CTMX | MSFT | Winner |
|---|---|---|---|
| Market Cap | $1.04B | N/A | CTMX |
| P/E Ratio | N/A | 26.46 | MSFT |
| EPS (TTM) | $N/A | $15.98 | MSFT |
| Revenue Growth | -1.0% | 0.2% | MSFT |
| Gross Margin | 100.0% | 68.6% | CTMX |
Analyze CTMX
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CTMX or MSFT a better investment?
Comparing CTMX and MSFT: Cytomx Therapeutics Inc has a market cap of $1.04B while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CTMX and MSFT?
CTMX (Cytomx Therapeutics Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CTMX or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CTMX or MSFT?
MSFT has higher revenue growth at 0.2% vs -1.0% for CTMX.
Which company is more profitable: CTMX or MSFT?
Cytomx Therapeutics Inc (CTMX) has higher gross margins at 100.0% compared to 68.6% for MSFT.
Which is the larger company: CTMX or MSFT?
Cytomx Therapeutics Inc (CTMX) is larger with a market cap of $1.04B compared to N/A for MSFT.
Should I buy CTMX or MSFT in 2026?
Both CTMX and MSFT have investment merit. CTMX trades at $4.82 while MSFT trades at $417.51. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CTMX and MSFT stock?
Key differences: Market Cap ($1.04B vs N/A), P/E Ratio (N/A vs 26.5x), Revenue Growth (-1.0% vs 0.2%), Gross Margin (100.0% vs 68.6%).